S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 97.5 TWD -0.51% Market Closed
Market Cap: 11.7B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCI Pharmtech Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Operating Income
NT$145.3m
CAGR 3-Years
-35%
CAGR 5-Years
-26%
CAGR 10-Years
-5%
Y
YungShin Global Holding Corp
TWSE:3705
Operating Income
NT$1.1B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
4%
Formosa Laboratories Inc
TWSE:4746
Operating Income
NT$737.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
12%
ScinoPharm Taiwan Ltd
TWSE:1789
Operating Income
NT$442.1m
CAGR 3-Years
8%
CAGR 5-Years
-1%
CAGR 10-Years
-7%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Operating Income
NT$4.5B
CAGR 3-Years
27%
CAGR 5-Years
38%
CAGR 10-Years
55%
Standard Chem & Pharm Co Ltd
TWSE:1720
Operating Income
NT$1.3B
CAGR 3-Years
21%
CAGR 5-Years
25%
CAGR 10-Years
16%
No Stocks Found

SCI Pharmtech Inc
Glance View

Market Cap
11.7B TWD
Industry
Pharmaceuticals

SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others

Intrinsic Value
47.66 TWD
Overvaluation 51%
Intrinsic Value
Price
S

See Also

What is SCI Pharmtech Inc's Operating Income?
Operating Income
145.3m TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Operating Income amounts to 145.3m TWD.

What is SCI Pharmtech Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-5%

Over the last year, the Operating Income growth was -28%. The average annual Operating Income growth rates for SCI Pharmtech Inc have been -35% over the past three years , -26% over the past five years , and -5% over the past ten years .

Back to Top